ABCA1 and neuroblastoma: Meanwhile, ABCB1 (P-glycoprotein) overexpression in NB promotes therapy resistance by effluxing cytotoxic drugs, with signaling pathways like Ras/ERK1/2/HIF-1α further exacerbating ABCA1 suppression and cholesterol dysregulation (145, 157).